Pay in 4 interest-free payments of $6.76 Learn more
Ships within 48 hours · Estimated delivery Sep 5 - Sep 10
"Lilly remains confident in the differentiated benefits of tirzepatide, the first and only dual GIP/GLP-1 receptor agonist approved to treat adults with obesity and adults with type two diabetes," the company said in an email statement to The Canadian Press
Understanding these differences helps you identify whether your reactions stem from the tirzepatide itself or from the specific formulation you are using
Besides, any break in the cold chain, whether during air transport, warehouse storage, local delivery, or patient handling, can render the medication ineffective or potentially unsafe
Additional Safety Information Contraindications: Zepbound is contraindicated in patients with a personal or family history of medullary thyroid carcinoma (MTC) or in patients with Multiple Endocrine Neoplasia syndrome type 2 (MEN 2)
Even moderate activities like walking can make a difference in appetite control
Use in Pregnancy Semaglutide has not been testing in pregnant women
US$ 25.92
US$ 22.94
US$ 23.60
